Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis
- 1 August 2007
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 293 (2), H949-H958
- https://doi.org/10.1152/ajpheart.01341.2006
Abstract
Familial hypertrophic cardiomyopathy (FHC) is a disease caused by mutations in contractile proteins of the sarcomere. Our laboratory developed a mouse model of FHC with a mutation in the thin filament protein α-tropomyosin (TM) at amino acid 180 (Glu180Gly). The hearts of these mice exhibit dramatic systolic and diastolic dysfunction, and their myofilaments demonstrate increased calcium sensitivity. The mice also develop severe cardiac hypertrophy, with death ensuing by 6 mo. In an attempt to normalize calcium sensitivity in the cardiomyofilaments of the hypertrophic mice, we generated a chimeric α-/β-TM protein that decreases calcium sensitivity in transgenic mouse cardiac myofilaments. By mating mice from these two models together, we tested the hypothesis that an attenuation of myofilament calcium sensitivity would modulate the severe physiological and pathological consequences of the FHC mutation. These double-transgenic mice “rescue” the hypertrophic phenotype by exhibiting a normal morphology with no pathological abnormalities. Physiological analyses of these rescued mice show improved cardiac function and normal myofilament calcium sensitivity. These results demonstrate that alterations in calcium response by modification of contractile proteins can prevent the pathological and physiological effects of this disease.Keywords
This publication has 26 references indexed in Scilit:
- A beneficial role of cardiac P2X4 receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Parvalbumin Corrects Slowed Relaxation in Adult Cardiac Myocytes Expressing Hypertrophic Cardiomyopathy-Linked α-Tropomyosin MutationsCirculation Research, 2004
- Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an α-tropomyosin mutation linked to familial hypertrophic cardiomyopathyJournal of Molecular and Cellular Cardiology, 2003
- Functional Importance of the Carboxyl-terminal Region of Striated Muscle TropomyosinJournal of Biological Chemistry, 2003
- Myofilament Calcium Sensitivity and Cardiac DiseaseCirculation Research, 2002
- A Familial Hypertrophic Cardiomyopathy α -Tropomyosin Mutation Causes Severe Cardiac Hypertrophy and Death in MiceJournal of Molecular and Cellular Cardiology, 2001
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban AblationPublished by Elsevier ,2001
- Clinical Features of Hypertrophic Cardiomyopathy Caused by Mutation of a “Hot Spot” in the Alpha-Tropomyosin GeneJournal of the American College of Cardiology, 1997
- Molecular and Physiological Effects of Overexpressing Striated Muscle β-Tropomyosin in the Adult Murine HeartJournal of Biological Chemistry, 1995